These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3515949)

  • 1. Cefotetan in the treatment of obstetric and gynecologic infections.
    Poindexter AN; Sweet R; Ritter M
    Am J Obstet Gynecol; 1986 Apr; 154(4):946-50. PubMed ID: 3515949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
    Sweet RL; Gall SA; Gibbs RS; Hemsell DL; Knuppel RA; Lane TW; Miller RD; Newton ER; Poindexter AN; Reguero W
    Am J Surg; 1988 May; 155(5A):56-60. PubMed ID: 3287970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
    Knuppel RA; O'Bryan D; Lake M
    South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections.
    Hemsell DL; Wendel GD; Gall SA; Newton ER; Gibbs RS; Knuppel RA; Lane TW; Sweet RL
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):722-7. PubMed ID: 3281462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cephalosporin therapy in intraabdominal infections. A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin.
    Wilson SE; Boswick JA; Duma RJ; Echols RM; Jemsek JG; Lerner R; Lewis RT; Najem AZ; Press RA; Rittenbury MS
    Am J Surg; 1988 May; 155(5A):61-6. PubMed ID: 3287971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cephamycins in obstetrics and gynecology.
    Sweet RL
    J Reprod Med; 1990 Nov; 35(11 Suppl):1064-9. PubMed ID: 2277374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections.
    Lewis RT; Duma RJ; Echols RM; Jemsek JG; Najem AZ; Press RA; Stone HH; Ton GT; Wilson SE
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):728-35. PubMed ID: 3281463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections.
    Scalambrino S; Mangioni C; Milani R; Regallo M; Norchi S; Negri L; Carrera S; Vigano EF; Ruffilli MP; Canale MP
    Suppl Int J Gynecol Obstet; 1989; 2():21-7. PubMed ID: 2679680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of new cephamycins in the management of obstetric and gynecologic infections.
    Jones RN
    J Reprod Med; 1990 Nov; 35(11 Suppl):1070-7. PubMed ID: 2277375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
    Wilson SE
    J Chemother; 1989 Jul; 1(4 Suppl):820-2. PubMed ID: 16312655
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of cefotetan and cefoxitin as prophylaxis in cesarean section.
    Varner MW; Weiner CP; Petzold CR; Galask RP
    Am J Obstet Gynecol; 1986 Apr; 154(4):951-4. PubMed ID: 3515950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotetan versus cefoxitin as prophylaxis in hysterectomy.
    Orr JW; Varner RE; Kilgore LC; Holloway RC; McDiarmid M
    Am J Obstet Gynecol; 1986 Apr; 154(4):960-3. PubMed ID: 3515952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxalactam: clinical summary of efficacy and safety.
    Kammer RB
    Rev Infect Dis; 1982; 4 Suppl():S712-9. PubMed ID: 6218589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report on a comparative trial of cefotetan and cefoxitin in the treatment of urinary tract infections.
    Cox CE; Childs SJ; Wells WG; Mirelmant S; Lesky WC
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():227-32. PubMed ID: 6341350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of expanded spectrum cephalosporins for the treatment of obstetrical and gynecological infections.
    Mercer LJ
    Obstet Gynecol Surv; 1988 Sep; 43(9):569-75. PubMed ID: 3145476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue.
    Geckler RW; Eng RH; Fabian TC; Echols RM; Jemsek JG; LeFrock JL; Mogabgab WC; Wilson SE
    Am J Surg; 1988 May; 155(5A):91-5. PubMed ID: 3287976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a randomized, multicenter, comparative trial of a single dose of cefotetan versus multiple doses of cefoxitin as prophylaxis in cesarean section.
    McGregor JA; Gordon SF; Krotec J; Poindexter AN
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):701-6. PubMed ID: 3281461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens.
    Sochalski A; Sullman S; Andriole VT
    Am J Surg; 1988 May; 155(5A):96-101. PubMed ID: 3132048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a multicenter comparative study of single-dose cefotetan and multiple-dose cefoxitin as prophylaxis in patients undergoing cesarean section.
    Galask RP; Benigno BB; Cunningham FG; Elliott JP; Makowski E; McGregor JA; Poindexter A
    Am J Surg; 1988 May; 155(5A):86-90. PubMed ID: 3287975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.